NEW YORK, NY — Nearly 6% of patients undergoing transcatheter aortic-valve replacement (TAVR) will experience a late major bleeding complication, and these bleeding events are associated with a ...

Repeat transcatheter aortic valve replacement (TAVR) with a balloon-expandable valve is effective in treating a failed first transcatheter valve, with low procedural risks and with clinical outcomes ...

2025 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- A new study on Managed Care is now available. According to news reporting originating in Atlanta, Georgia, by ...

MARLBOROUGH, Mass., Sept. 17, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) has announced results from the PROTECTED TAVR clinical trial evaluating the SENTINEL™ Cerebral Protection ...

Ohio hospitals are evaluating their transcatheter aortic valve replacement programs after recent data showed a higher mortality rate and cost than average, the Scioto Valley Guardian reported May 17.

The number of deaths and disabling strokes among patients at low surgical risk who were treated with transcatheter aortic valve replacement (TAVR) remained lower at three years, but not significantly ...

Bethesda Heart, part of Bethesda Heart Hospital East in Boynton Beach, Fla., has performed its 100th transcatheter aortic valve replacement in under two years since launching the TAVR program in March ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

BOSTON — Changes in devices and procedural care were the biggest factor in improvements in short-term outcomes for patients undergoing transcatheter aortic valve replacement, researchers reported at ...

The potential is high for TAVR adoption in emerging markets, according to Venkat Rajan, an analyst at Frost & Sullivan. “It is, however, coming in at a higher price point than traditional valves,” he ...